Sunday, July 13, 2014





Ameridose in Mass. to remain closed through year


February 19. 2013 5:43PM
Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle


(AP) A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year.


Ameridose first agreed to close for inspection in October after tainted steroids from its sister company, the New England Compounding Center, were linked to a fungal meningitis outbreak that caused 32 deaths. The agreement has been extended several times. The latest would have expired Monday.


Ameridose has laid off most workers and recalled its products, though none has been found contaminated. The company makes injectable drugs for hospitals.


The U.S. Food and Drug Administration said Monday that its monthlong inspection of Ameridose found potential sources of contamination, including leaky ceilings and insects. Ameridose has said it'll work to address those issues.


Associated Press


Comments
comments powered by Disqus Commenting Guidelines
Poll
Mortgage Minute


Search for New & Used Cars

Make 
Model
 
Used New All
 

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals



Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds